MNDY vs PRME · P/E 32, rev $1.23B vs rev $4.6M
Monday.Com Ltd (MNDY) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
MNDY currently screens at market cap $3.79B and trailing P/E 32.1. PRME currently screens at market cap $570.8M.
Not investment advice. Open the MNDY and PRME stock pages for the full models.
Not investment advice.